Literature DB >> 7742352

Interaction of sphingomyelinase with sphingomyelin analogs modified at the C-1 and C-3 positions of the sphingosine backbone.

M D Lister1, Z S Ruan, R Bittman.   

Abstract

In this study, analogs differing at the C-1 or C-3 position of the sphingosine backbone of sphingomyelin were examined in neutral pH-optimum sphingomyelinase assays. Two analogs modified at the C-1 position, ceramide-1-phosphate and ceramide-1-phosphoethanol-N,N-dimethylamine, could act as modest substrates but showed no ability to inhibit the reaction when egg sphingomyelin was used as the substrate. Four analogs of sphingomyelin differing at the C-3 position were used in which the hydroxyl group was replaced by a hydrogen atom (to give a deoxy-sphingomyelin analog), or with a O-methyl, O-ethyl or O-tetrahydropyranyl group. The deoxy analog showed no ability to compete with substrate of sphingomyelinase nor could it be hydrolyzed by the enzyme, suggesting that the hydroxyl group is a required substituent for the substrate. The 3-O-methyl and 3-O-ethyl-sphingomyelin analogs were inhibitors, with IC50 values of 50 microM and 140 microM, respectively at standard assay conditions. However, when the rat brain acidic pH-optimum sphingomyelinase was used, no inhibition by the 3-O-methyl analog could be detected. The size of the alkyl group on the ether moiety was important, as shown by the inability of 3-O-tetrahydropyranyl-sphingomyelin to compete with substrate of neutral pH-optimum sphingomyelinase.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7742352     DOI: 10.1016/0005-2760(94)00249-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

1.  Trafficking of endogenous smooth muscle cell cholesterol: a role for serum amyloid A and interleukin-1β.

Authors:  Lawrence G Pessolano; Christopher P Sullivan; Stephanie E Seidl; Celeste B Rich; Laura Liscum; Phillip J Stone; Jean D Sipe; Barbara M Schreiber
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-09-20       Impact factor: 8.311

Review 2.  Drug targeting of sphingolipid metabolism: sphingomyelinases and ceramidases.

Authors:  Daniel Canals; David M Perry; Russell W Jenkins; Yusuf A Hannun
Journal:  Br J Pharmacol       Date:  2011-06       Impact factor: 8.739

3.  Lithocholic acid disrupts phospholipid and sphingolipid homeostasis leading to cholestasis in mice.

Authors:  Tsutomu Matsubara; Naoki Tanaka; Andrew D Patterson; Joo-Youn Cho; Kristopher W Krausz; Frank J Gonzalez
Journal:  Hepatology       Date:  2011-04       Impact factor: 17.425

4.  Betamethasone modulation of sphingomyelin hydrolysis up-regulates CTP:cholinephosphate cytidylyltransferase activity in adult rat lung.

Authors:  R K Mallampalli; S N Mathur; L J Warnock; R G Salome; G W Hunninghake; F J Field
Journal:  Biochem J       Date:  1996-08-15       Impact factor: 3.857

Review 5.  Small Molecule Inhibitors Targeting Biosynthesis of Ceramide, the Central Hub of the Sphingolipid Network.

Authors:  Jan Skácel; Barbara S Slusher; Takashi Tsukamoto
Journal:  J Med Chem       Date:  2021-01-04       Impact factor: 7.446

6.  Sphingomyelins suppress the targeted disruption of lysosomes/endosomes by the photosensitizer NPe6 during photodynamic therapy.

Authors:  Joseph A Caruso; Patricia A Mathieu; John J Reiners
Journal:  Biochem J       Date:  2005-12-01       Impact factor: 3.857

7.  TNF-α- and tumor-induced skeletal muscle atrophy involves sphingolipid metabolism.

Authors:  Joffrey De Larichaudy; Alessandra Zufferli; Filippo Serra; Andrea M Isidori; Fabio Naro; Kevin Dessalle; Marine Desgeorges; Monique Piraud; David Cheillan; Hubert Vidal; Etienne Lefai; Georges Némoz
Journal:  Skelet Muscle       Date:  2012-01-18       Impact factor: 4.912

8.  Behavior of 1-Deoxy-, 3-Deoxy- and N-Methyl-Ceramides in Skin Barrier Lipid Models.

Authors:  Andrej Kováčik; Petra Pullmannová; Ludmila Pavlíková; Jaroslav Maixner; Kateřina Vávrová
Journal:  Sci Rep       Date:  2020-03-02       Impact factor: 4.379

9.  Amyloid-beta peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway.

Authors:  Jiunn-Tay Lee; Jan Xu; Jin-Moo Lee; Grace Ku; Xianlin Han; Ding-I Yang; Shawei Chen; Chung Y Hsu
Journal:  J Cell Biol       Date:  2004-01-05       Impact factor: 10.539

10.  Stereoselective synthesis of (2S,3S,4Z)-4-fluoro-1,3-dihydroxy-2-(octadecanoylamino)octadec-4-ene, [(Z)-4-fluoroceramide], and its phase behavior at the air/water interface.

Authors:  Gergana S Nikolova; Günter Haufe
Journal:  Beilstein J Org Chem       Date:  2008-04-25       Impact factor: 2.883

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.